Conversely, chronic activation of NF-κB signaling is frequently detected in numerous human inflammatory diseases and cancer, including gastric tumorigenesis (Hedvat et al., 2009; Lu et al., 2014; Yang et al., 2015). This evidence concerns the gene NFKB1 and cancer.